Effects of Kampo formula on oxidative stress

Effects of Kampo formula on oxidative stress - Kampo and oxidative stress

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000035547

Enrollment

Registered

2019-02-01

Start date

2019-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who receives Kampo formula treatments

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patient diagnosed as "Sho (pattern)" to the corresponding Kampo formula. 2. Patient newly treated with the corresponding Kampo formula for more than 12 weeks. 3. Patients who showed consent to this research. Kampo: Go-sha-jinki-Gan, Hachimi-jio-Gan, Saiko-ka-ryukotsu-borei-To, Oren-gedoku-To, Keishi-bukuryo-Gan, Toki-shakuyaku-San, Saiko-keishi-kankyo-To, Kami-kihi-To.

Exclusion criteria

Exclusion criteria: 1. Those who can not obtain consent to participate in research. 2. Those who can not express self-will 3. Those judged to be inappropriate by the researchers or research sharing doctor 4. Those who already medicated with Kampo formulation(s) constantly, and change(s) or addition(s) of new Kampo formulation(s) are made within the two weeks before the start of this investigation.

Design outcomes

Primary

Measure	Time frame
Oxidative stress marker (MULTIS)	—

Secondary

Measure	Time frame
Oxidative stress and inflammation markers: iStrap, IL-6, TNF-a, adiponectin, CRP	—

Countries

Japan

Contacts

Public ContactAki Hirayama

Tsukuba University of Technology Center for Integrative Medicine

aki-hira@k.tsukuba-tech.ac.jp0298589590

Outcome results